DuChemBIO Statistics

Total Valuation

DuChemBIO has a market cap or net worth of KRW 305.84 billion. The enterprise value is 310.92 billion.

Market Cap	305.84B
Enterprise Value	310.92B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

DuChemBIO has 28.34 million shares outstanding.

Current Share Class	28.34M
Shares Outstanding	28.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.96%
Owned by Insiders (%)	9.36%
Owned by Institutions (%)	n/a
Float	10.45M

Valuation Ratios

The trailing PE ratio is 38.66 and the forward PE ratio is 19.55.

PE Ratio	38.66
Forward PE	19.55
PS Ratio	8.58
PB Ratio	7.04
P/TBV Ratio	12.51
P/FCF Ratio	59.11
P/OCF Ratio	45.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.47, with an EV/FCF ratio of 60.10.

EV / Earnings	40.86
EV / Sales	8.72
EV / EBITDA	27.47
EV / EBIT	54.45
EV / FCF	60.10

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.37.

Current Ratio	1.64
Quick Ratio	1.56
Debt / Equity	0.37
Debt / EBITDA	1.52
Debt / FCF	3.10
Interest Coverage	4.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	9.85%
Revenue Per Employee	310.05M
Profits Per Employee	66.17M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.41B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.84% in the last 52 weeks. The beta is 0.03, so DuChemBIO's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+43.84%
50-Day Moving Average	15,408.80
200-Day Moving Average	11,621.55
Relative Strength Index (RSI)	27.83
Average Volume (20 Days)	1,199,908

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DuChemBIO had revenue of KRW 35.66 billion and earned 7.61 billion in profits. Earnings per share was 279.09.

Revenue	35.66B
Gross Profit	12.26B
Operating Income	4.95B
Pretax Income	5.20B
Net Income	7.61B
EBITDA	10.56B
EBIT	4.95B
Earnings Per Share (EPS)	279.09

Full Income Statement

Balance Sheet

The company has 11.35 billion in cash and 16.06 billion in debt, giving a net cash position of -4.71 billion or -166.06 per share.

Cash & Cash Equivalents	11.35B
Total Debt	16.06B
Net Cash	-4.71B
Net Cash Per Share	-166.06
Equity (Book Value)	43.41B
Book Value Per Share	1,518.38
Working Capital	8.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.74 billion and capital expenditures -1.57 billion, giving a free cash flow of 5.17 billion.

Operating Cash Flow	6.74B
Capital Expenditures	-1.57B
Free Cash Flow	5.17B
FCF Per Share	182.53

Full Cash Flow Statement

Margins

Gross margin is 34.39%, with operating and profit margins of 13.90% and 21.34%.

Gross Margin	34.39%
Operating Margin	13.90%
Pretax Margin	14.58%
Profit Margin	21.34%
EBITDA Margin	29.63%
EBIT Margin	13.90%
FCF Margin	14.51%

Dividends & Yields

DuChemBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.49%
FCF Yield	1.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DuChemBIO has an Altman Z-Score of 10.51 and a Piotroski F-Score of 2.

Altman Z-Score	10.51
Piotroski F-Score	2